Listar por autor "Huergo Zapico, Leticia"

Analysis of clinical prognostic variables for Chronic Lymphocytic Leukemia decision-making problems

Andrés Galiana, Enrique Juan de

; Fernández Martínez, Juan Luis

; Luaces Rodríguez, Óscar

; Coz Velasco, Juan José del

; Huergo Zapico, Leticia

; Acebes Huerta, Andrea

; González Rodríguez, Segundo

; González Rodríguez, Ana Pilar

(Elsevier, 2016-04)

Diferencias en la respuesta inmunitaria mediada por NKG2D en cánceres epiteliales y mesenquimales

Huergo Zapico, Leticia

(2014-07-11)

Drug-induced hyperploidy stimulates an antitumor NK cell response mediated by NKG2D and DNAM-1 receptors

Acebes Huerta, Andrea

; Lorenzo Herrero, Seila

; Rodríguez Folgueras, Alicia

; Huergo Zapico, Leticia

; López Larrea, Carlos

; López Soto, Alejandro

; González Rodríguez, Segundo

(2016)

Epithelial-mesenchymal transition induces an anti-tumor immune response mediated by NKG2D receptor

Huergo Zapico, Leticia

; López Soto, Alejandro

; Rodrigo Sáez, Luis Ricardo

; García de Herreros Madueño, Antonio; Astudillo González, María Aurora

; González Rodríguez, Segundo

(2012)

Epithelial-mesenchymal transition induces an antitumor immune response mediated by NKG2D receptor

López Soto, Alejandro

; Huergo Zapico, Leticia

; Galván Hernández, José Alberto

; Rodrigo Sáez, Luis Ricardo

; Garcí de Herreros, Antonio; Astudillo González, María Aurora

; González Rodríguez, Segundo

(2013)

Expansion of NK cells and reduction of NKG2D expression in chronic lymphocytic leukemia.Correlation with progressive disease

Huergo Zapico, Leticia

; Acebes Huerta, Andrea

; González Rodríguez, Ana Pilar

; Contesti, Juan Facundo

; González García, María Esther

; Payer, Ángel R.; Villa Álvarez, Mónica

; Fernández Guizán, Azahara

; López Soto, Alejandro

; González Rodríguez, Segundo

(2014)

Expression of ERp5 and GRP78 on the membrane of chronic lymphocytic leukemia cells: association with soluble MICA shedding

Huergo Zapico, Leticia

; González Rodríguez, Ana Pilar

; Contesti, Juan Facundo

; González García, María Esther

; López Soto, Alejandro

; Fernández Guizán, Azahara

; Acebes Huerta, Andrea

; Toyos González, Juan Ramón de los

; López Larrea, Carlos

; Groh, Veronika; Spies, Thomas; González Rodríguez, Segundo

(2012)

Ig-like transcript 2 (ILT2) suppresses T cell function in chronic lymphocytic leukemia

Villa Álvarez, Mónica

; Lorenzo Herrero, Seila

; González Rodríguez, Ana Pilar

; López Soto, Alejandro

; Ramírez Payer, Ángel; González García, María Esther

; Huergo Zapico, Leticia

; González Rodríguez, Segundo

(2017)

Lenalidomide and Chronic Lymphocytic Leukemia

González Rodríguez, Ana Pilar

; Payer, Ángel R.; Acebes Huerta, Andrea

; Huergo Zapico, Leticia

; Villa Álvarez, Mónica

; González García, María Esther

; González Rodríguez, Segundo

(2013)

Lenalidomide Induces Immunomodulation in Chronic Lymphocytic Leukemia and Enhances Antitumor Immune Responses Mediated by NK and CD4 T Cells

Acebes Huerta, Andrea

; Huergo Zapico, Leticia

; González Rodríguez, Ana Pilar

; Fernández Guizán, Azahara

; Payer, Ángel R.; López Soto, Alejandro

; González Rodríguez, Segundo

(Hindawi Publishing Corporation, 2014)

Molecular bases for the regulation of NKG2D ligands in cancer

Huergo Zapico, Leticia

; Acebes Huerta, Andrea

; López Soto, Alejandro

; Villa Álvarez, Mónica

; González Rodríguez, Ana Pilar

; González Rodríguez, Segundo

(Frontiers, 2014)

NK Cells, Tumor Cell Transition, and Tumor Progression in Solid Malignancies: New Hints for NK-Based Immunotherapy?

Cantoni, Claudia; Huergo Zapico, Leticia

; Parodi, Mónica; Pedrazzi, Marco; Mingari, María Cristina; Moretta, Alessandro; Sparatore, Bianca; González Rodríguez, Segundo

; Olive, Daniel; Bottino, Cristina; Castriconi, Roberta; Vitale, Massimo (2016)

NK-cell editing mediates epithelial-to-mesenchymal transition via phenotypic and proteomic changes in melanoma cell lines

Huergo Zapico, Leticia

; Parodi, Mónica; Cantoni, Claudia; Fernández Martínez, Juan Luis

; Andrés Galiana, Enrique Juan de

; López Soto, Alejandro

; González Rodríguez, Segundo

(2018)

NKG2D signaling in cancer immunosurveillance

López Soto, Alejandro

; Huergo Zapico, Leticia

; Acebes Huerta, Andrea

; Villa Álvarez, Mónica

; González Rodríguez, Segundo

(2014)

Patients with psoriatic arthritis may show differences in their clinical and genetic profiles depending on their age at psoriasis onset

Queiro Silva, Rubén

; Alperi López, Mercedes

; Alonso Castro, Sara

; Ballina García, Francisco Javier

; Huergo Zapico, Leticia

; Fernández Guizán, Azahara

; Acebes Huerta, Andrea

; Martínez Borra, Jesús

; Sarasqueta Eizaguirre, Cristina

; López Larrea, Carlos

; González Rodríguez, Segundo

(2012)

Pleiotropic Anti-Angiogenic and Anti-Oncogenic Activities of the Novel Mithralog Demycarosyl-3D-beta-D-Digitoxosyl-Mithramycin SK (EC-8042)

Fernández Guizán, Azahara

; López Soto, Alejandro

; Acebes Huerta, Andrea

; Huergo Zapico, Leticia

; Villa Álvarez, Mónica

; Núñez González, Luz Elena

; Morís Varas, Francisco; González Rodríguez, Segundo

(2015)

Prognostic significance of CD8 and CD4 T cells in chronic lymphocytic leukemia

González Rodríguez, Ana Pilar

; Contesti, Juan Facundo

; Huergo Zapico, Leticia

; López Soto, Alejandro

; Fernández Guizán, Azahara

; Acebes Huerta, Andrea

; González Huerta, Ana Julia; González, E.; Fernández Álvarez, Carmen

; González Rodríguez, Segundo

(2010)

Regulation of NKG2D signaling during the epithelial-to-mesenchymal transition

López Soto, Alejandro

; Huergo Zapico, Leticia

; Acebes Huerta, Andrea

; Rodrigo Sáez, Luis Ricardo

; González Rodríguez, Segundo

(2013)

Listar por autor "Huergo Zapico, Leticia"

Analysis of clinical prognostic variables for Chronic Lymphocytic Leukemia decision-making problems ﻿

Diferencias en la respuesta inmunitaria mediada por NKG2D en cánceres epiteliales y mesenquimales ﻿

Drug-induced hyperploidy stimulates an antitumor NK cell response mediated by NKG2D and DNAM-1 receptors ﻿

Epithelial-mesenchymal transition induces an anti-tumor immune response mediated by NKG2D receptor ﻿

Epithelial-mesenchymal transition induces an antitumor immune response mediated by NKG2D receptor ﻿

Expansion of NK cells and reduction of NKG2D expression in chronic lymphocytic leukemia.Correlation with progressive disease ﻿

Expression of ERp5 and GRP78 on the membrane of chronic lymphocytic leukemia cells: association with soluble MICA shedding ﻿

Ig-like transcript 2 (ILT2) suppresses T cell function in chronic lymphocytic leukemia ﻿

Lenalidomide and Chronic Lymphocytic Leukemia ﻿

Lenalidomide Induces Immunomodulation in Chronic Lymphocytic Leukemia and Enhances Antitumor Immune Responses Mediated by NK and CD4 T Cells ﻿

Molecular bases for the regulation of NKG2D ligands in cancer ﻿

NK Cells, Tumor Cell Transition, and Tumor Progression in Solid Malignancies: New Hints for NK-Based Immunotherapy? ﻿

NK-cell editing mediates epithelial-to-mesenchymal transition via phenotypic and proteomic changes in melanoma cell lines ﻿

NKG2D signaling in cancer immunosurveillance ﻿

Patients with psoriatic arthritis may show differences in their clinical and genetic profiles depending on their age at psoriasis onset ﻿

Pleiotropic Anti-Angiogenic and Anti-Oncogenic Activities of the Novel Mithralog Demycarosyl-3D-beta-D-Digitoxosyl-Mithramycin SK (EC-8042) ﻿

Prognostic significance of CD8 and CD4 T cells in chronic lymphocytic leukemia ﻿

Regulation of NKG2D signaling during the epithelial-to-mesenchymal transition ﻿

Analysis of clinical prognostic variables for Chronic Lymphocytic Leukemia decision-making problems

Diferencias en la respuesta inmunitaria mediada por NKG2D en cánceres epiteliales y mesenquimales

Drug-induced hyperploidy stimulates an antitumor NK cell response mediated by NKG2D and DNAM-1 receptors

Epithelial-mesenchymal transition induces an anti-tumor immune response mediated by NKG2D receptor

Epithelial-mesenchymal transition induces an antitumor immune response mediated by NKG2D receptor

Expansion of NK cells and reduction of NKG2D expression in chronic lymphocytic leukemia.Correlation with progressive disease

Expression of ERp5 and GRP78 on the membrane of chronic lymphocytic leukemia cells: association with soluble MICA shedding

Ig-like transcript 2 (ILT2) suppresses T cell function in chronic lymphocytic leukemia

Lenalidomide and Chronic Lymphocytic Leukemia

Lenalidomide Induces Immunomodulation in Chronic Lymphocytic Leukemia and Enhances Antitumor Immune Responses Mediated by NK and CD4 T Cells

Molecular bases for the regulation of NKG2D ligands in cancer

NK Cells, Tumor Cell Transition, and Tumor Progression in Solid Malignancies: New Hints for NK-Based Immunotherapy?

NK-cell editing mediates epithelial-to-mesenchymal transition via phenotypic and proteomic changes in melanoma cell lines

NKG2D signaling in cancer immunosurveillance

Patients with psoriatic arthritis may show differences in their clinical and genetic profiles depending on their age at psoriasis onset

Pleiotropic Anti-Angiogenic and Anti-Oncogenic Activities of the Novel Mithralog Demycarosyl-3D-beta-D-Digitoxosyl-Mithramycin SK (EC-8042)

Prognostic significance of CD8 and CD4 T cells in chronic lymphocytic leukemia

Regulation of NKG2D signaling during the epithelial-to-mesenchymal transition